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1. Introduction
  The advent of antimicrobial chemotherapy and antisepsis 
appear to have given rise to a major side effect “resistance”, 
of which Joseph Lister (1827-1912) and his co-travellers, 
perhaps, least anticipated at the outset [1-3].  The 
susceptibility patterns of bacteria vary among organisms 
and species as well as the class of antimicrobial used[4-6]. 
This scenario has contributed to the challenges, most often 
physicians and other health professional encounter in the 
management of life threatening bacterial infections[7-9]. 
  In the midst of growing widespread resistance by micro-
organisms, management of post-operative surgical 
infections have continued to pose a serious challenge to 
health personnel saddled with such responsibilities world 
over[10-12]. Pseudomonas aeruginosa (P. aeruginosa) has 
been listed in several instances among the most notorious 
of bacteria complicating surgical site infections (SSIs)[13,14]. 
This is in view of its wide spread resistance against most of 
the antimicrobials readily available for management of its 
infections. In Cairo, Egypt, all the isolates of P. aeruginosa 
were found to be resistant to ampicillin, cloxacillin and 
co-trimoxazole[15]; and in Ilorin Nigeria, the susceptibility 
pattern of P. aeruginosa to cloxacillin, erythromycin, 
azithromycin and ceftazidime ranged from <50-90% of the 
92 isolates recovered[16]. Of the 92 isolates of P. aeruginosa 
recovered in Zaria, 19.6% were resistant to three or more 
drugs tested, the commonest combination being ceftazi
dime+perfloxacin+ofloxacin[17]. Also from South Africa, 
100%, 75%, 30% and 10% of the isolates of P. aeruginosa 
were sensitive to colistin, gentamicin, streptomycin, and 
tetracycline respectively[18]. 
  Since effective management of post-operative wound 
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infections contributes to the overall success of a surgical 
procedure, proper knowledge of the antimicrobial profile 
of the most important complicating micro-organisms 
becomes necessary. Such  information may be useful to 
surgeons probably in the pre-, intra- and post- operative 
antimicrobial prophylaxis of patients in order to achieve 
successful surgical outcomes. 
2. Materials and methods
2.1. Study area
  The study was carried out at University of Calabar 
Teaching Hospital (UCTH), which is situated in Calabar city, 
the capital of Cross Rivers State. 
2.2. Procedure
  The study was retrospective in nature; data generated 
from the antibiotic susceptibility pattern of bacteria 
recovered from post operative wound swab specimens were 
compiled for a period of five years (1st February, 2004- 
31st January, 2009). All the post-operative wound swab 
specimens processed and documented during the period 
under review were considered. Specimens were collected, 
transported, stored and processed using standard laboratory 
procedures[19]. Briefly, cotton wool tipped swab sticks 
were used to collect wound swab samples; microscopy was 
carried out on the specimens after gram staining, and then 
inoculated into appropriate culture media for incubation. 
Modified Kirby-Bauer’s diffusion method was used to 
carry out susceptibility testing. Other relevant information 
concerning patients were obtained from their records[20].
2.3. Analysis of results
 The results were analysed by using Epi Info 6, statistical 
software, P values ＜ 0.05 were considered significant.
3. Results
  During the period under review, 4 533 wound swab 
specimens were processed at UCTH Calabar Medical 
Microbiology laboratory; the lowest and highest number of 
specimens were aged≥80 and 60-69 years, 7(0.1%) and 
1 013(22.3%) respectively. Forty seven percent (n=2 127) and 
53.1% (n=2 406) were males and females respectively. Table 
1 shows the age and gender distribution of patients with 
post-operative wound infections.
  Micro-organisms were recovered from 673 (14.8%) of the 
specimens processed comprising Staphylococcus aureus 
20.2% (n=136); Coagulase negative Staphylococcus 10.1% 
(n=68); Escherichia coli 19.0% (n=128); Streptococcus 
pyogenes 11.7% (n=79); Klebsiella spp. 10.0% (n=67); 
Citrobacter/Enterobacter 2.8% (n=19); Proteus spp. 7.3% 
(n=49); Enterococcus spp. 1.9% (n=13) and P. aeruginosa 
13.1% (n=88).   
  Based on sources of specimens among the 88 isolates of 
P. aeruginosa, 14.8% (n=13); 2.2% (n= 2); 19.3% (n=17) and 
16.0% (n=14) isolates of the organism were recovered from 
ENT, Ophthalmic, Maternity and Gynaecologic Wards, while 
19.3% (n=17); 21.6% (n=19) and 6.8% (n=6) of the infections 
were from Orthopaedic, General Surgery, and Accidents & 
Emergency Wards respectively.
  Analysis of rate of isolation of P. aeruginosa based on 
gender showed that 1.8% (39/2 127) and 2.0% (49/2 406) 
of the male and female gender were respectively infected 
with the organism. This difference was not statistically 
significant (P>0.05). Figure 1 showed the result of isolation of 
P. aeruginosa from post-operative wound infections based 
on gender of the subjects.
  A review of the rate of isolation of P. aeruginosa based on 
age of the subjects showed a significantly low infection rates 
at the extremes of age (P<0.05). 0-9 years and >80 years had 
0.0% and 1.1%, respectively, whereas, those aged 10-19 
years and 40-49 years with 19.3% and 18.2% infection rates 
recorded respectively. Figure 1 showed the isolation of P. 
aeruginosa from post-operative wound infections based on 
age of subjects.
  All the isolates of P. aeruginosa were resistant to ampicillin 
and tetracycline while a sensitivity of 0.7%, 58%, 52%, 37%, 
32%, and 63% was recorded against co-trimoxazole, colistin, 
gentamicin, streptomycin, erythromycin and augmentin. The 
sensitivity of the organism to Ofloxacin and ceftriaxone was 
98% and 96% respectively. Figure 2 showed the antimicrobial 
susceptibility pattern of P. aeruginosa recovered from post-
operative wound infections. 
        
Age intervals(Years)
Figure 1. Isolation of P. aeruginosa from post-operative wound 
infections based on age of subjects.
Table 1 
Age and gender distribution of patients with post-operative wound 
infections [n(%)].
Age (Years) Male Female Total 
0-9   59 (1.3)   86 (1.9)   145 (3.2)
10-19   452 (10.0) 333 (7.3)     785 (17.3)
20-29 202 (4.5)  401 (8.8)     603 (13.3)
30-39 379 (8.4) 198 (4.4)     577 (12.8)
40-49 411 (9.1) 277 (6.1)     688 (15.2)
50-59 319 (7.0) 172 (3.8)     491 (10.8)
60-69 258 (5.7)   755 (16.7) 1 013 (22.3)
70-79   41 (0.9) 164 (3.6)   205 (4.5)
80 & Above     2 (0.0)     5 (0.1)       7 (0.1)
Unclassified     4 (0.1)   15 (0.3)     19 (0.4)
Total 2 127(47.0) 2 406(53.0) 4 533(100.0)
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X2 (Mantel-Haenszel)= 10.47, OR= 0.00, P= 0.001.
Figure 2. Antimicrobial susceptibility pattern of P. aeruginosa 
recovered from post-operative wound infections.
4. Discussion
  P. aeruginosa was found to account for 13.1% (n=88) 
of the 673 wound swab specimens from suspected post-
operative wound infections, majority of the isolates being 
from general surgical ward with significantly higher rates in 
the younger age groups compared to the older (P<0.05); but 
without gender difference (P<0.05). The higher rate of P. 
aeruginosa infection in children compared to adults may be 
attributed to the differential in integrity in innate immunity 
being supposedly the lower in the children compared to 
adults[21,22]. This probably inadvertently complements the 
inherent virulent factors of the organism usually associated 
with its disease perpetuation and pathogenesis[23,24].
  The drugs with the highest activity against P. aeruginosa 
during the study period were Ofloxacin (98%), ceftriaxone 
(96%) and augmentin (63%), and those with the lowest 
activity were ampicillin (0%), tetracycline (0%) and co-
trimoxazole (7%) among the isolates tested. The fact that 
no antibiotic was able to record a 100% activity against 
all the P. aeruginosa isolates tested shows the high profile 
multiple resistance, the organism has attained in present 
day medicine[25,26]. This could pose a serious threat in 
the management of wound infections especially in health 
centres in the rural and semi-urban communities in the 
country where facilities to clearly show its antimicrobial 
susceptibility profile on its isolation may be lacking. The 
sensitivity pattern similar to this present one was also 
reported in Taipei, Taiwan[18] and Chennai, India[16] where 
activities of most quinolones were found to be almost 100% 
against P. aeruginosa, although the organism accounted 
for over 20% of the bacterial isolates recovered from SSIs. 
Also Vyhnanek et al in Czech republic[27] similarly reported 
that none of the drugs tested in the study centre had 
100% activity against P. aeruginosa including the newly 
introduced tygecycline of which the organism was 100% 
resistant. Contrary to findings in the present study however, 
the organism along with other Gram negative bacilli 
recovered from emergency departments of major hospitals 
in Beijing, China had sensitivity patterns similar to that of 
the nosocomial isolates and the resistance pattern generally 
appeared to be on the decline[28]. This feat achieved in 
Beijing was attributed largely to improvement in regulation 
and control of retail, prescription and intake of antibiotics 
which is a good example for the present global war against 
antimicrobial resistance[24-27]. 
  It is therefore emphasized that adequate pre-, intra-, and 
post-operative precautions need to be taken seriously in the 
preparation as well as in the handling of surgical patients so 
as to prevent colonization of this highly multiply resistant 
bacteria and other bacteria that may share similar resistant 
traits[29,30]. In addition, the institution of a functional infection 
control committee with a competent surveillance machinery 
and provision of a competent and elaborate antibiotic 
policy is strongly advocated for hospitals and clinics in the 
country[23,31]. This would, to a large extent, impact positively 
both on the incidences of post-operative wound infections 
as well as the rate of emergence of antimicrobial resistance 
by streamlining the mode of prescription, sale as well as 
intake of these drugs[8,9]. This position has also been well 
corroborated by Licker et al in Romania[32], Juan et al in 
Spain[33], and Huang et al in Shanghai China[34].
  In conclusion, this study has also re-affirmed the strains of 
P. aeruginosa, which are multiply resistant, are among the 
most common isolates from post operative wound infections. 
Proper management of patients before, during and after 
surgery will help to prevent the challenge of confronting 
these multiply resistant microbes such as P. aeruginosa, and 
also general control of infection in the hospital environment. 
Furthermore, Ofloxacin, ceftriaxonr and augmentin may be 
considered on isolation of the micro-organism.  
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